论文部分内容阅读
流行性出血热(EHF)迄今尚无特效疗法。1993年1月～1995年1月我们用病毒唑治疗51例早期EHF患者,就其临床疗效进行观察,现报告如下。 1.1 病例选择 本文共选择病例88例,均为发病5日内的住院病人。临床诊断符合1987年EHF(试行)防治方案,按入院先后次序随机分为两组:治疗组51人,男41例,女10例。年龄15～66岁,平均37.05±1.88岁。其中轻型16例,中型25例,重型8例,危重型2例。对照组37例,男30例,女7例。年龄7～61岁,平均37.20±2.35岁。其中轻型14例,
Epidemic haemorrhagic fever (EHF) so far no effective therapy. January 1993 ~ January 1995 we use ribavirin treatment of 51 cases of early EHF patients, the clinical efficacy of the observation, are as follows. 1.1 Case Selection In this paper, a total of 88 cases were selected, all within 5 days of onset of hospitalized patients. Clinical diagnosis in line with the 1987 EHF (trial) prevention and treatment programs, according to admission order were randomly divided into two groups: the treatment group of 51 people, 41 males and 10 females. Aged 15 to 66 years old, with an average of 37.05 ± 1.88 years. Including 16 cases of light, 25 cases of medium, heavy in 8 cases, 2 cases of critical type. Control group 37 cases, 30 males and 7 females. Aged 7 to 61 years old, with an average of 37.20 ± 2.35 years old. Of which 14 cases of light,